• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Discovery and Innovation >From Plants to Medicine for Management of Sickle Cell Disorder
【24h】

From Plants to Medicine for Management of Sickle Cell Disorder

机译：从植物到药物治疗镰状细胞疾病

获取原文
获取原文并翻译 | 示例
       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Health challenges are so enormous in sub-Saharan Africa that only substantial injection of resources and strong partnerships involving national authorities, multilateral agencies, local communities, the private sector and other stakeholders can address the situation. Based on recent advances in science and technology, the development of new interventions for diagnosis, prevention and treatment has been accelerated. Africa has not been able to participate as a functional partner in generating new knowledge neither has it the capacity and political commitment to capitalize on this exciting development. Due to disparities in economic strength, political will, scientific resources and capabilities, Africa has lagged behind in accessing the available global knowledge. Health research systems, like most others, require long-term investments by national governments and partners but it is the duty of the national government to create an enabling environment for conducting research. Indeed, it has been suggested that health investments yield the highest rates of return compared to other public investments.
机译：在撒哈拉以南非洲，卫生挑战如此之大，以至于只有大量的资源投入以及涉及国家主管部门，多边机构，地方社区，私营部门和其他利益攸关方的强有力的伙伴关系，才能解决这一问题。基于科学和技术的最新进展，加快了诊断，预防和治疗新干预措施的开发。非洲无法作为职能合作伙伴参与产生新知识，也没有能力和政治承诺来利用这一令人振奋的发展。由于经济实力，政治意愿，科学资源和能力方面的差异，非洲在获取可用的全球知识方面一直落后。与大多数其他卫生研究系统一样，卫生研究系统也需要国家政府和合作伙伴的长期投资，但是国家政府的责任是为开展研究创造有利的环境。确实，有人建议，与其他公共投资相比，卫生投资的回报率最高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号